Tracking the Selective Pressure Profile and Gene Flow of SARS-CoV-2 Delta Variant in Italy from April to October 2021 and Frequencies of Key Mutations from Three Representative Italian Regions.
SARS-CoV-2 Delta variant
gene flows
mutations
selective pressure
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
27 Oct 2023
27 Oct 2023
Historique:
received:
19
09
2023
revised:
19
10
2023
accepted:
20
10
2023
medline:
25
11
2023
pubmed:
25
11
2023
entrez:
25
11
2023
Statut:
epublish
Résumé
The SARS-CoV-2 Delta variant of concern (VOC) was often associated with serious clinical course of the COVID-19 disease. Herein, we investigated the selective pressure, gene flow and evaluation on the frequencies of mutations causing amino acid substitutions in the Delta variant in three Italian regions. A total of 1500 SARS-CoV-2 Delta genomes, collected in Italy from April to October 2021 were investigated, including a subset of 596 from three Italian regions. The selective pressure and the frequency of amino acid substitutions and the prediction of their possible impact on the stability of the proteins were investigated. Delta variant dataset, in this study, identified 68 sites under positive selection: 16 in the spike (23.5%), 11 in nsp2 (16.2%) and 10 in nsp12 (14.7%) genes. Three of the positive sites in the spike were located in the receptor-binding domain (RBD). In Delta genomes from the three regions, 6 changes were identified as very common (>83.7%), 4 as common (>64.0%), 21 at low frequency (2.1%-25.0%) and 29 rare (≤2.0%). The detection of positive selection on key mutations may represent a model to identify recurrent signature mutations of the virus.
Identifiants
pubmed: 38004656
pii: microorganisms11112644
doi: 10.3390/microorganisms11112644
pmc: PMC10673055
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : This study was partly granted by the Italian Ministry of Health
ID : CCM 2020 - Title: "Caratterizzazione molecolare del virus pandemico SARS-CoV-2 in Italia"
Références
AIDS Res Hum Retroviruses. 2011 Nov;27(11):1173-82
pubmed: 21453131
J Biol Chem. 2021 Oct;297(4):101208
pubmed: 34543625
Front Med (Lausanne). 2022 Nov 10;9:995960
pubmed: 36438034
PLoS One. 2023 Sep 14;18(9):e0291271
pubmed: 37708144
Mol Biol Evol. 2005 May;22(5):1208-22
pubmed: 15703242
J Med Virol. 2022 Apr;94(4):1738-1744
pubmed: 34905235
Mol Biol Evol. 2013 May;30(5):1196-205
pubmed: 23420840
Viruses. 2022 Nov 12;14(11):
pubmed: 36423117
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Genetics. 1989 Nov;123(3):603-13
pubmed: 2599370
Mol Biol Evol. 2005 Mar;22(3):478-85
pubmed: 15509724
Bioinformatics. 2005 Mar 1;21(5):676-9
pubmed: 15509596
J Autoimmun. 2022 Jan;126:102779
pubmed: 34915422
Vaccines (Basel). 2022 Nov 14;10(11):
pubmed: 36423021
Front Microbiol. 2023 Aug 08;14:1222301
pubmed: 37614597
Viruses. 2022 Mar 19;14(3):
pubmed: 35337047
Elife. 2020 Oct 28;9:
pubmed: 33112236
Genetics. 1998 Mar;148(3):929-36
pubmed: 9539414
Front Immunol. 2021 Nov 30;12:751778
pubmed: 34917076
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544
pubmed: 29790989
Emerg Microbes Infect. 2021 Dec;10(1):2010-2015
pubmed: 34651569
Viruses. 2022 Oct 19;14(10):
pubmed: 36298851
Nature. 2021 Jul;595(7869):707-712
pubmed: 34098568
Cell Host Microbe. 2021 Mar 10;29(3):477-488.e4
pubmed: 33535027
Front Microbiol. 2022 Jul 28;13:934993
pubmed: 35966675
Heliyon. 2020 Sep;6(9):e05001
pubmed: 32984566
Mol Biol Evol. 2005 Dec;22(12):2472-9
pubmed: 16107592
PLoS One. 2022 Mar 28;17(3):e0265579
pubmed: 35344550
Int J Infect Dis. 2023 Apr;129:135-141
pubmed: 36708869
Cell. 2021 Apr 29;184(9):2332-2347.e16
pubmed: 33761326
Mol Biol Evol. 2013 May;30(5):1188-95
pubmed: 23418397